UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002192
Receipt number R000002683
Scientific Title Effects of antihypertensive therapy on platelet function and insulin sensitivity in patients with glucose intolerance
Date of disclosure of the study information 2009/07/13
Last modified on 2021/01/25 17:19:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of antihypertensive therapy on platelet function and insulin sensitivity in patients with glucose intolerance

Acronym

Effects of antihypertensive therapy on platelet function and insulin sensitivity

Scientific Title

Effects of antihypertensive therapy on platelet function and insulin sensitivity in patients with glucose intolerance

Scientific Title:Acronym

Effects of antihypertensive therapy on platelet function and insulin sensitivity

Region

Japan


Condition

Condition

patients with glucose intolerance and hypertension

Classification by specialty

Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assessment of the effects on platelet function and insulin sensitivity among antihypertensive drugs.

Basic objectives2

Others

Basic objectives -Others

Comparison of the effects on platelet function and insulin sensitivity among the therapy with calcium channel blocker, angiotensin converting enzyme inhibitor and angiotensin receptor blocker

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

platelet aggregation

Key secondary outcomes

plasma glucose level, plasma IRI level


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

antihypertensive therapy for 60d with calcium channel blocker(Amlodipine)

Interventions/Control_2

antihypertensive therapy for 60d with angiotensin converting enzyme blocker (Enalapril)

Interventions/Control_3

antihypertensive therapy for 60d with angiotensin receptor blocker (Losartan)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

non-treated patients having fasting plasma glucose level more than 100 mg/dl and systolic blood pressure more than 130 mmHg and diastolic blood pressure more than 80 mmHg

Key exclusion criteria

1) patients having pregnancy, severe liver, kidney or heart disease
2) patients who have already treated with statin, biguanide or thiazolidine
3) patients who have a history of drug allergy

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo Kajita

Organization

Gifu University School of Medicine

Division name

General Internal Medicine

Zip code


Address

Yanagido 1-1, Gifu, 501-1194

TEL

058-230-6000

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kazuo Kajita

Organization

Gifu University School of Medicine

Division name

General Internal Medicine

Zip code


Address

Yanagido 1-1, Gifu, 501-1194

TEL

058-230-6000

Homepage URL


Email

kkajita@gifu-u.ac.jp


Sponsor or person

Institute

Gifu University School of Medicine, General Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Banyu Pharmaceutical Co

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2009 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 08 Month 01 Day

Last follow-up date

2012 Year 07 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete

2012 Year 12 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 07 Month 13 Day

Last modified on

2021 Year 01 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002683


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name